Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 7 member 2 is a membrane transporter protein that mediates the uptake of cationic amino acids, particularly arginine, lysine, and ornithine, across the plasma membrane in a sodium- and pH-independent manner. It plays an essential role in immune cell metabolism, especially in macrophages, serving as a key modulator of inflammatory processes via regulation of nitric oxide and polyamine production. SLC7A2 is inducible and exists in multiple splice isoforms with different substrate affinities. Its expression influences cell proliferation, migration, and immune responses, with implications for cancer progression (notably ovarian and colon cancer), infectious diseases, and inflammatory conditions. Reduced expression of SLC7A2 correlates with increased tumor cell viability, invasion, and poorer prognosis in several cancers.
Modulation of transporter function to alter amino acid availability and downstream metabolic pathways (e.g., nitric oxide synthesis in immune responses).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 7 member 2 (SLC7A2).